40 related articles for article (PubMed ID: 20617254)
1. Use of ultra-high performance liquid chromatography-high-resolution mass spectroscopy to profile the metabolites from the serum of patients with breast cancer.
Zhang Q; Lu R; Wu Y; Hong Y; Wang N; Wang C
Oncol Lett; 2024 May; 27(5):209. PubMed ID: 38549802
[TBL] [Abstract][Full Text] [Related]
2. Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome.
Holm M; Joenväärä S; Saraswat M; Mustonen H; Tohmola T; Ristimäki A; Renkonen R; Haglund C
FASEB Bioadv; 2019 Dec; 1(12):723-730. PubMed ID: 32123817
[TBL] [Abstract][Full Text] [Related]
3. Urinary Metabolic Profiling of Liver Fluke-Induced Cholangiocarcinoma-A Follow-Up Study.
Alsaleh M; Sithithaworn P; Khuntikeo N; Loilome W; Yongvanit P; Hughes T; O'Connor T; Andrews RH; Wadsworth CA; Williams R; Koomson L; Cox IJ; Holmes E; Taylor-Robinson SD
J Clin Exp Hepatol; 2023; 13(2):203-217. PubMed ID: 36950498
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic Comparison of Patients With Colorectal Cancer at Different Anticancer Treatment Stages.
Li Z; Deng X; Luo J; Lei Y; Jin X; Zhu J; Lv G
Front Oncol; 2021; 11():574318. PubMed ID: 35186705
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Volatilome and Metabolome Signatures of Colorectal Cancer in Urine: A Systematic Review and Meta-Analysis.
Mallafré-Muro C; Llambrich M; Cumeras R; Pardo A; Brezmes J; Marco S; Gumà J
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34064065
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the Urinary Metabolic Profile of Liver Fluke-Associated Cholangiocarcinoma.
Alsaleh M; Sithithaworn P; Khuntikeo N; Loilome W; Yongvanit P; Chamadol N; Hughes T; O'Connor T; Andrews RH; Holmes E; Taylor-Robinson SD
J Clin Exp Hepatol; 2019; 9(6):657-675. PubMed ID: 31889746
[TBL] [Abstract][Full Text] [Related]
7. Nutritional Metabolomics in Cancer Epidemiology: Current Trends, Challenges, and Future Directions.
McGee EE; Kiblawi R; Playdon MC; Eliassen AH
Curr Nutr Rep; 2019 Sep; 8(3):187-201. PubMed ID: 31129888
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review.
Erben V; Bhardwaj M; Schrotz-King P; Brenner H
Cancers (Basel); 2018 Jul; 10(8):. PubMed ID: 30060469
[TBL] [Abstract][Full Text] [Related]
9. Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare).
Liesenfeld DB; Habermann N; Toth R; Owen RW; Frei E; Staffa J; Schrotz-King P; Klika KD; Ulrich CM
Metabolomics; 2015 Aug; 11(4):998-1012. PubMed ID: 29250455
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a High-Throughput Mass Spectrometry Based Urine Metabolomic Test for the Detection of Colonic Adenomatous Polyps.
Deng L; Chang D; Foshaug RR; Eisner R; Tso VK; Wishart DS; Fedorak RN
Metabolites; 2017 Jun; 7(3):. PubMed ID: 28640228
[No Abstract] [Full Text] [Related]
11. Role of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-Analysis.
Altobelli E; Angeletti PM; Latella G
J Cancer; 2016; 7(14):1984-2004. PubMed ID: 27877214
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a highly sensitive urine-based test to identify patients with colonic adenomatous polyps.
Wang H; Tso V; Wong C; Sadowski D; Fedorak RN
Clin Transl Gastroenterol; 2014 Mar; 5(3):e54. PubMed ID: 24646506
[TBL] [Abstract][Full Text] [Related]
13. A machine-learned predictor of colonic polyps based on urinary metabolomics.
Eisner R; Greiner R; Tso V; Wang H; Fedorak RN
Biomed Res Int; 2013; 2013():303982. PubMed ID: 24307992
[TBL] [Abstract][Full Text] [Related]
14. Review of mass spectrometry-based metabolomics in cancer research.
Liesenfeld DB; Habermann N; Owen RW; Scalbert A; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2182-201. PubMed ID: 24096148
[TBL] [Abstract][Full Text] [Related]
15. Urinary metabolic profiling of colorectal carcinoma based on online affinity solid phase extraction-high performance liquid chromatography and ultra performance liquid chromatography-mass spectrometry.
Wang W; Feng B; Li X; Yin P; Gao P; Zhao X; Lu X; Zheng M; Xu G
Mol Biosyst; 2010 Oct; 6(10):1947-55. PubMed ID: 20617254
[TBL] [Abstract][Full Text] [Related]
16. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
18. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.
Issaq HJ; Nativ O; Waybright T; Luke B; Veenstra TD; Issaq EJ; Kravstov A; Mullerad M
J Urol; 2008 Jun; 179(6):2422-6. PubMed ID: 18433783
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
